Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The immune system is an assembly of structures and processes inside the body to protect against possibly damaging foreign bodies and diseases. It identifies various threats like bacteria, viruses, and parasites and distinguishes them from body's healthy tissues. When the immune system weakness and lose the capability to detect and destroy the abnormal cells or body attacks and damages its tissues lead to diseases like cancer and autoimmune diseases. Immunotherapy is a process which includes the treatment by inducing, enhancing or suppressing an immune system to fight against the diseases.
This report offers an overview of the market trends, drivers, and barriers with respect to the China Immunology Drug market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Immunology Drug market. Detailed analysis of key players, along with key growth strategies adopted by Immunology Drug industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
GlaxoSmithKline plc
Genentech
Seattle Genetics
Eli Lilly and Company
Abbott Laboratories
Pfizer
Bayer AG
Active Biotech
By Type:
Monoclonal Antibodies (mAb)
Antibody Drug Conjugates
Interferon and Cytokine therapies
Immunosuppressive medication
By End-User:
Hospitals
Clinics
Cancer Research Centers and Institutes
By Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Immunology Drug Market
-
1.3 Market Segment by Type
-
1.3.1 China Immunology Drug Market Size and Growth Rate of Monoclonal Antibodies (mAb) from 2016 to 2027
-
1.3.2 China Immunology Drug Market Size and Growth Rate of Antibody Drug Conjugates from 2016 to 2027
-
1.3.3 China Immunology Drug Market Size and Growth Rate of Interferon and Cytokine therapies from 2016 to 2027
-
1.3.4 China Immunology Drug Market Size and Growth Rate of Immunosuppressive medication from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 China Immunology Drug Market Size and Growth Rate of Hospitals from 2016 to 2027
-
1.4.2 China Immunology Drug Market Size and Growth Rate of Clinics from 2016 to 2027
-
1.4.3 China Immunology Drug Market Size and Growth Rate of Cancer Research Centers and Institutes from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 North China Immunology Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 Central China Immunology Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 South China Immunology Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 East China Immunology Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.5 Northeast China Immunology Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.6 Southwest China Immunology Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.7 Northwest China Immunology Drug Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Immunology Drug Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Immunology Drug by Major Types
-
3.4.1 Market Size and Growth Rate of Monoclonal Antibodies (mAb)
-
3.4.2 Market Size and Growth Rate of Antibody Drug Conjugates
-
3.4.3 Market Size and Growth Rate of Interferon and Cytokine therapies
-
3.4.4 Market Size and Growth Rate of Immunosuppressive medication
4 Segmentation of Immunology Drug Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Immunology Drug by Major End-Users
-
4.4.1 Market Size and Growth Rate of Immunology Drug in Hospitals
-
4.4.2 Market Size and Growth Rate of Immunology Drug in Clinics
-
4.4.3 Market Size and Growth Rate of Immunology Drug in Cancer Research Centers and Institutes
5 Market Analysis by Regions
-
5.1 China Immunology Drug Production Analysis by Regions
-
5.2 China Immunology Drug Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on China Economy
6 North China Immunology Drug Landscape Analysis
-
6.1 North China Immunology Drug Landscape Analysis by Major Types
-
6.2 North China Immunology Drug Landscape Analysis by Major End-Users
7 Central China Immunology Drug Landscape Analysis
-
7.1 Central China Immunology Drug Landscape Analysis by Major Types
-
7.2 Central China Immunology Drug Landscape Analysis by Major End-Users
8 South China Immunology Drug Landscape Analysis
-
8.1 South China Immunology Drug Landscape Analysis by Major Types
-
8.2 South China Immunology Drug Landscape Analysis by Major End-Users
9 East China Immunology Drug Landscape Analysis
-
9.1 East China Immunology Drug Landscape Analysis by Major Types
-
9.2 East China Immunology Drug Landscape Analysis by Major End-Users
10 Northeast China Immunology Drug Landscape Analysis
-
10.1 Northeast China Immunology Drug Landscape Analysis by Major Types
-
10.2 Northeast China Immunology Drug Landscape Analysis by Major End-Users
11 Southwest China Immunology Drug Landscape Analysis
-
11.1 Southwest China Immunology Drug Landscape Analysis by Major Types
-
11.2 Southwest China Immunology Drug Landscape Analysis by Major End-Users
12 Northwest China Immunology Drug Landscape Analysis
-
12.1 Northwest China Immunology Drug Landscape Analysis by Major Types
-
12.2 Northwest China Immunology Drug Landscape Analysis by Major End-Users
13 Major Players Profiles
-
13.1 GlaxoSmithKline plc
-
13.1.1 GlaxoSmithKline plc Company Profile and Recent Development
-
13.1.2 Market Performance
-
13.1.3 Product and Service Introduction
-
13.2 Genentech
-
13.2.1 Genentech Company Profile and Recent Development
-
13.2.2 Market Performance
-
13.2.3 Product and Service Introduction
-
13.3 Seattle Genetics
-
13.3.1 Seattle Genetics Company Profile and Recent Development
-
13.3.2 Market Performance
-
13.3.3 Product and Service Introduction
-
13.4 Eli Lilly and Company
-
13.4.1 Eli Lilly and Company Company Profile and Recent Development
-
13.4.2 Market Performance
-
13.4.3 Product and Service Introduction
-
13.5 Abbott Laboratories
-
13.5.1 Abbott Laboratories Company Profile and Recent Development
-
13.5.2 Market Performance
-
13.5.3 Product and Service Introduction
-
13.6 Pfizer
-
13.6.1 Pfizer Company Profile and Recent Development
-
13.6.2 Market Performance
-
13.6.3 Product and Service Introduction
-
13.7 Bayer AG
-
13.7.1 Bayer AG Company Profile and Recent Development
-
13.7.2 Market Performance
-
13.7.3 Product and Service Introduction
-
13.8 Active Biotech
-
13.8.1 Active Biotech Company Profile and Recent Development
-
13.8.2 Market Performance
-
13.8.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure China Immunology Drug Market Size and Growth Rate of Monoclonal Antibodies (mAb) from 2016 to 2027
-
Figure China Immunology Drug Market Size and Growth Rate of Antibody Drug Conjugates from 2016 to 2027
-
Figure China Immunology Drug Market Size and Growth Rate of Interferon and Cytokine therapies from 2016 to 2027
-
Figure China Immunology Drug Market Size and Growth Rate of Immunosuppressive medication from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2021
-
Figure Market Share by Type in 2027
-
Figure China Immunology Drug Market Size and Growth Rate of Hospitals from 2016 to 2027
-
Figure China Immunology Drug Market Size and Growth Rate of Clinics from 2016 to 2027
-
Figure China Immunology Drug Market Size and Growth Rate of Cancer Research Centers and Institutes from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2021
-
Figure Market Share by End-User in 2027
-
Figure North China Immunology Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Central China Immunology Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South China Immunology Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure East China Immunology Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast China Immunology Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Southwest China Immunology Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northwest China Immunology Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Immunology Drug Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2020
-
Figure Market Share of TOP 5 Players in 2021
-
Figure Market Share of TOP 6 Players from 2016 to 2021
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Map of China
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Immunology Drug
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Immunology Drug by Different Types from 2016 to 2027
-
Table Consumption Share of Immunology Drug by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Monoclonal Antibodies (mAb)
-
Figure Market Size and Growth Rate of Antibody Drug Conjugates
-
Figure Market Size and Growth Rate of Interferon and Cytokine therapies
-
Figure Market Size and Growth Rate of Immunosuppressive medication
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Immunology Drug by Different End-Users from 2016 to 2027
-
Table Consumption Share of Immunology Drug by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Hospitals
-
Figure Market Size and Growth Rate of Clinics
-
Figure Market Size and Growth Rate of Cancer Research Centers and Institutes
-
Table China Immunology Drug Production by Regions
-
Table China Immunology Drug Production Share by Regions
-
Figure China Immunology Drug Production Share by Regions in 2016
-
Figure China Immunology Drug Production Share by Regions in 2021
-
Figure China Immunology Drug Production Share by Regions in 2027
-
Table China Immunology Drug Consumption by Regions
-
Table China Immunology Drug Consumption Share by Regions
-
Figure China Immunology Drug Consumption Share by Regions in 2016
-
Figure China Immunology Drug Consumption Share by Regions in 2021
-
Figure China Immunology Drug Consumption Share by Regions in 2027
-
Table North China Immunology Drug Consumption by Types from 2016 to 2027
-
Table North China Immunology Drug Consumption Share by Types from 2016 to 2027
-
Figure North China Immunology Drug Consumption Share by Types in 2016
-
Figure North China Immunology Drug Consumption Share by Types in 2021
-
Figure North China Immunology Drug Consumption Share by Types in 2027
-
Table North China Immunology Drug Consumption by End-Users from 2016 to 2027
-
Table North China Immunology Drug Consumption Share by End-Users from 2016 to 2027
-
Figure North China Immunology Drug Consumption Share by End-Users in 2016
-
Figure North China Immunology Drug Consumption Share by End-Users in 2021
-
Figure North China Immunology Drug Consumption Share by End-Users in 2027
-
Table Central China Immunology Drug Consumption by Types from 2016 to 2027
-
Table Central China Immunology Drug Consumption Share by Types from 2016 to 2027
-
Figure Central China Immunology Drug Consumption Share by Types in 2016
-
Figure Central China Immunology Drug Consumption Share by Types in 2021
-
Figure Central China Immunology Drug Consumption Share by Types in 2027
-
Table Central China Immunology Drug Consumption by End-Users from 2016 to 2027
-
Table Central China Immunology Drug Consumption Share by End-Users from 2016 to 2027
-
Figure Central China Immunology Drug Consumption Share by End-Users in 2016
-
Figure Central China Immunology Drug Consumption Share by End-Users in 2021
-
Figure Central China Immunology Drug Consumption Share by End-Users in 2027
-
Table South China Immunology Drug Consumption by Types from 2016 to 2027
-
Table South China Immunology Drug Consumption Share by Types from 2016 to 2027
-
Figure South China Immunology Drug Consumption Share by Types in 2016
-
Figure South China Immunology Drug Consumption Share by Types in 2021
-
Figure South China Immunology Drug Consumption Share by Types in 2027
-
Table South China Immunology Drug Consumption by End-Users from 2016 to 2027
-
Table South China Immunology Drug Consumption Share by End-Users from 2016 to 2027
-
Figure South China Immunology Drug Consumption Share by End-Users in 2016
-
Figure South China Immunology Drug Consumption Share by End-Users in 2021
-
Figure South China Immunology Drug Consumption Share by End-Users in 2027
-
Table East China Immunology Drug Consumption by Types from 2016 to 2027
-
Table East China Immunology Drug Consumption Share by Types from 2016 to 2027
-
Figure East China Immunology Drug Consumption Share by Types in 2016
-
Figure East China Immunology Drug Consumption Share by Types in 2021
-
Figure East China Immunology Drug Consumption Share by Types in 2027
-
Table East China Immunology Drug Consumption by End-Users from 2016 to 2027
-
Table East China Immunology Drug Consumption Share by End-Users from 2016 to 2027
-
Figure East China Immunology Drug Consumption Share by End-Users in 2016
-
Figure East China Immunology Drug Consumption Share by End-Users in 2021
-
Figure East China Immunology Drug Consumption Share by End-Users in 2027
-
Table Northeast China Immunology Drug Consumption by Types from 2016 to 2027
-
Table Northeast China Immunology Drug Consumption Share by Types from 2016 to 2027
-
Figure Northeast China Immunology Drug Consumption Share by Types in 2016
-
Figure Northeast China Immunology Drug Consumption Share by Types in 2021
-
Figure Northeast China Immunology Drug Consumption Share by Types in 2027
-
Table Northeast China Immunology Drug Consumption by End-Users from 2016 to 2027
-
Table Northeast China Immunology Drug Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast China Immunology Drug Consumption Share by End-Users in 2016
-
Figure Northeast China Immunology Drug Consumption Share by End-Users in 2021
-
Figure Northeast China Immunology Drug Consumption Share by End-Users in 2027
-
Table Southwest China Immunology Drug Consumption by Types from 2016 to 2027
-
Table Southwest China Immunology Drug Consumption Share by Types from 2016 to 2027
-
Figure Southwest China Immunology Drug Consumption Share by Types in 2016
-
Figure Southwest China Immunology Drug Consumption Share by Types in 2021
-
Figure Southwest China Immunology Drug Consumption Share by Types in 2027
-
Table Southwest China Immunology Drug Consumption by End-Users from 2016 to 2027
-
Table Southwest China Immunology Drug Consumption Share by End-Users from 2016 to 2027
-
Figure Southwest China Immunology Drug Consumption Share by End-Users in 2016
-
Figure Southwest China Immunology Drug Consumption Share by End-Users in 2021
-
Figure Southwest China Immunology Drug Consumption Share by End-Users in 2027
-
Table Northwest China Immunology Drug Consumption by Types from 2016 to 2027
-
Table Northwest China Immunology Drug Consumption Share by Types from 2016 to 2027
-
Figure Northwest China Immunology Drug Consumption Share by Types in 2016
-
Figure Northwest China Immunology Drug Consumption Share by Types in 2021
-
Figure Northwest China Immunology Drug Consumption Share by Types in 2027
-
Table Northwest China Immunology Drug Consumption by End-Users from 2016 to 2027
-
Table Northwest China Immunology Drug Consumption Share by End-Users from 2016 to 2027
-
Figure Northwest China Immunology Drug Consumption Share by End-Users in 2016
-
Figure Northwest China Immunology Drug Consumption Share by End-Users in 2021
-
Figure Northwest China Immunology Drug Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of GlaxoSmithKline plc
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline plc
-
Figure Sales and Growth Rate Analysis of GlaxoSmithKline plc
-
Figure Revenue and Market Share Analysis of GlaxoSmithKline plc
-
Table Product and Service Introduction of GlaxoSmithKline plc
-
Table Company Profile and Development Status of Genentech
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Genentech
-
Figure Sales and Growth Rate Analysis of Genentech
-
Figure Revenue and Market Share Analysis of Genentech
-
Table Product and Service Introduction of Genentech
-
Table Company Profile and Development Status of Seattle Genetics
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Seattle Genetics
-
Figure Sales and Growth Rate Analysis of Seattle Genetics
-
Figure Revenue and Market Share Analysis of Seattle Genetics
-
Table Product and Service Introduction of Seattle Genetics
-
Table Company Profile and Development Status of Eli Lilly and Company
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eli Lilly and Company
-
Figure Sales and Growth Rate Analysis of Eli Lilly and Company
-
Figure Revenue and Market Share Analysis of Eli Lilly and Company
-
Table Product and Service Introduction of Eli Lilly and Company
-
Table Company Profile and Development Status of Abbott Laboratories
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Abbott Laboratories
-
Figure Sales and Growth Rate Analysis of Abbott Laboratories
-
Figure Revenue and Market Share Analysis of Abbott Laboratories
-
Table Product and Service Introduction of Abbott Laboratories
-
Table Company Profile and Development Status of Pfizer
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer
-
Figure Sales and Growth Rate Analysis of Pfizer
-
Figure Revenue and Market Share Analysis of Pfizer
-
Table Product and Service Introduction of Pfizer
-
Table Company Profile and Development Status of Bayer AG
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bayer AG
-
Figure Sales and Growth Rate Analysis of Bayer AG
-
Figure Revenue and Market Share Analysis of Bayer AG
-
Table Product and Service Introduction of Bayer AG
-
Table Company Profile and Development Status of Active Biotech
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Active Biotech
-
Figure Sales and Growth Rate Analysis of Active Biotech
-
Figure Revenue and Market Share Analysis of Active Biotech
-
Table Product and Service Introduction of Active Biotech
-
